Cite

HARVARD Citation

    Esteve Pastor, M. et al. (n.d.). 2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study. European heart journal. p. . [Online]. 
  
Back to record